Empaheart-10MG Tab

Tablet

Type 2 diabetes mellitus (to improve glycaemic control along with diet and exercise); may also be used to reduce risk of cardiovascular death and hospitalization for heart failure in eligible patients as per physician advice.

Empagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion. This lowers blood sugar and can also promote mild diuresis and weight reduction.

Oral tablet. Usually taken once daily, preferably at the same time each day, with or without food. Swallow whole with water; dose and duration as prescribed. Maintain adequate hydration; monitor blood glucose as advised.

Increased urination,thirst,genital fungal infection (thrush),urinary tract infection,itching,low blood pressure/dizziness,nausea

Prescription-only antidiabetic. Risk of dehydration and low blood pressure—use caution in elderly, on diuretics, or with low BP. Can increase risk of genital mycotic infections and UTIs. Rare but serious: ketoacidosis (even with near-normal sugars), Fournier’s gangrene, severe allergic reactions—seek urgent care for nausea/vomiting, abdominal pain, rapid breathing, confusion, genital pain/swelling, fever. Not recommended in type 1 diabetes; avoid in severe renal impairment/ESRD/dialysis; renal function should be assessed before and during treatment. Temporarily stop before major surgery/acute serious illness as advised by doctor.

Diuretics (increased dehydration/hypotension),insulin or sulfonylureas (increased hypoglycaemia risk),other antihypertensives (additive BP lowering),lithium (may lower lithium levels),alcohol (raises ketoacidosis risk)

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep out of reach of children.

Jardiance 10 mg Tablet,Empa 10 mg Tablet,Empagliflozin 10 mg Tablet (generic),Glyxambi (empagliflozin+linagliptin) equivalent strength,Empagliflozin 10 mg brands (various)